Please login to the form below

New Accounts, July, 2009, PR & Med Ed

New pharmaceutical account wins notified to us by the winning agency for the period May 2009 and July 2009 inclusive

New pharmaceutical account wins notified to us by the winning agency for the period May 2009 and July 2009 inclusive:

CLIENT	PRODUCT	THERAPEUTIC AREA	WINNING AGENCY
AstraZeneca	N/A	Non-small cell lung cancer	Medaxial Group
AZ/BMS	Onglyza	Diabetes	Virgo HEALTH
Almirall	Solaraze	Dermatology	Signature Healthcare Communications
Biogen Idec	N/A	Neurology	Medaxial Group
BMS	Patient support	HIV	Hive
Boehringer Ingelheim	CME	Non-small cell lung cancer	Strategic Consultants International
The Hesley Group	N/A	Corporate	Clew Communications
Cranage Healthcare International	New product	Dermatology	Signature Healthcare Communications
Galderma	New product	Dermatology	Signature Healthcare Communications
GSK	Cervarix	Cervical cancer	Virgo HEALTH
IDIS	European and UK corporate	Corporate	Ogilvy Healthworld UK
Mundipharma	Strategic planning processes and European internal comms engagement	Corporate	JYC Global
Napp Pharmaceuticals	Oxycontin	Palliative Care	Signature Healthcare Communications
Novartis	NHS engagement	Diabetes, Hypertension, CV	JYC Global
Nutricia Advanced Medical Nutrition	Respifor	COPD	Virgo HEALTH
Nutricia Advanced Medical Nutrition	Conference support	Cross-brand	Virgo HEALTH
Orchid	Male cancer awareness week	Corporate	Spink
Schering-Plough	NHS project work	Cardiovascular	JYC Global
SKCIN	Corporate	Skin cancer	Signature Healthcare Communications

Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

29th July 2009

PME Digital Edition

Featured jobs

Systematic Reviewer - Oxford: Negotiable

Editorial Manager - MedComms: DOE

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Business Director: Competitive Salary Offered

Experienced Medical Writers: Competitive Salary and Benefits

Account Manager: Negotiable

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

Client Services Director – Medical Education Agency – North West...: Salary TBC

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Senior Account Executive with progression to Account Manager, Me...: Excellent package

Associate Director: £75, 000-90, 000

SAE – Healthcare PR – Award-Winning Consultancy: Salary TBC

Healthcare Advertising Senior Account Manager / AD / Senior AD: Salary TBC

Account Executive/ Senior Account Executive: competitive Salary Offfered

Manager - Immunology, Therapeutic Area Communications & Publ...: Competitive Salary Offered

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Associate Medical Director: Excellent PTO, bonus and 401k package

Account Manager / Senior Account Manager: 35, 000-40, 000

Healthcare Communications Account Directors x 2: Salary TBC

Account Manager- Healthcare Advertising: Negotiable

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Director: Competitive Salary Offered

Business Development Director – Health Education: excellent commission

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Subscribe to our email news alerts

PMHub

Add my company

PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

Navigating the antibiotic resistance crisis: Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls: ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today: Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...